These findings demonstrate that PACS‐2 supports NPSC‐mediated IVD regeneration by maintaining MAM integrity via the SP1/LRRK2/Mfn2 axis, offering potential therapeutic targets for IDD. The gene discussed is SP1; the disease is intervertebral disk degenerative disorder.